Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis

[1]  M. Brunetto,et al.  Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen , 1989, Hepatology.

[2]  Y. Stierhof,et al.  Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection , 1988, Journal of virology.

[3]  K. Murase,et al.  Pilot study of recombinant human interleukin 2 for chronic type B hepatitis , 1988, Hepatology.

[4]  J. Siegel.  Effects of interferon-? on the activation of human T lymphocytes , 1988 .

[5]  K. Murase,et al.  Interferon‐γ production by peripheral blood mononuclear cells of patients with chronic liver disease , 1987 .

[6]  T. Ikeda,et al.  Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life , 1986, Hepatology.

[7]  M. Aguet,et al.  Absence of detectable serum interferon in acute and chronic viral hepatitis , 1986, Hepatology.

[8]  H. Thomas,et al.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection , 1986, Hepatology.

[9]  U. Andersson,et al.  Phenotypic characterization of individual interferon‐γ‐producing cells after OKT3 antibody activation , 1986 .

[10]  S. Sherlock,et al.  TREATMENT OF CHRONIC HEPATITIS DUE TO HEPATITIS B VIRUS , 1985, The Lancet.

[11]  A. Dibisceglie,et al.  Recombinant leukocyte interferon treatment of chronic hepatitis B , 1985, Hepatology.

[12]  J. Chaput,et al.  Lack of in vivo activation of the interferon system in HBsAg‐positive chronic active hepatitis , 1985, Hepatology.

[13]  H. Thomas,et al.  An Analysis of the Composition of the Inflammatory Infiltrate in Autoimmune and Hepatitis B Virus‐Induced Chronic Liver Disease , 2007, Hepatology.

[14]  G. Colucci,et al.  In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. , 1983, Gastroenterology.

[15]  E. Rieber,et al.  Involvement of the cytotoxic/suppressor T-cell subset in liver tissue injury of patients with acute and chronic liver diseases , 1983 .

[16]  T. Yamaguchi,et al.  In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro. , 1983, Cellular immunology.

[17]  J. Rakela,et al.  Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. , 1983, Gastroenterology.

[18]  T. Waldmann,et al.  A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor , 1982, Nature.

[19]  N. Minato,et al.  In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. , 1982, Journal of the National Cancer Institute.

[20]  T. Merigan,et al.  Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. , 1981, Gastroenterology.

[21]  H. Hojo,et al.  Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432). , 1981, Gan.

[22]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[23]  S. Sherlock,et al.  Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. , 1981, Gastroenterology.

[24]  T. Waldmann,et al.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.

[25]  H. Saito,et al.  Enhanced Humoral Antibody Production in Mice against Influenza Virus by Streptococcal Preparation OK‐432 , 1981, Microbiology and immunology.

[26]  F. Chisari,et al.  Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness. , 1981, Journal of immunology.

[27]  K. Oshimi,et al.  Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. , 1980, Journal of the National Cancer Institute.

[28]  M. Rugge,et al.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection , 1980 .

[29]  K. Cantell,et al.  DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFERON ADMINISTRATION IN CHRONIC HBsAg-POSITIVE HEPATITIS , 1980, The Lancet.

[30]  K. Nomoto,et al.  Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice. , 1979, Clinical and experimental immunology.

[31]  E. Yunis,et al.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens , 1978, The Journal of experimental medicine.

[32]  T. Merigan,et al.  Effect of vidarabine on chronic hepatitis B virus infection. , 1978, JAMA.

[33]  K. Isselbacher,et al.  Alteration in suppressor cell activity in chronic active hepatitis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Merigan,et al.  Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. , 1976, The New England journal of medicine.

[35]  Noah Nd,et al.  Letter: Meningococcal infections. , 1975 .

[36]  R. Greenman,et al.  DNA Polymerase Associated with Human Hepatitis B Antigen , 1973, Journal of virology.